Advertisement

International Journal of Clinical Pharmacy

, Volume 35, Issue 3, pp 469–475 | Cite as

Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists

  • Kreshnik HotiEmail author
  • Jeffery Hughes
  • Bruce Sunderland
Research Article

Abstract

Background Community pharmacies and hospitals are the two main professional areas for pharmacists. There is currently a lack of comparison of pharmacists working in these two distinct settings in relation to an expanded prescribing role. Objective To compare the attitudes of hospital and community pharmacists regarding an expanded prescribing role. Setting Australian pharmacists. Methods A self-administered postal survey was used to collect the data. Data analysis was performed using SPSS® v19. Kendall’s tau-c test was used to compare the mean values between categorical variables (i.e. hospital or community pharmacists) and continuous variables measuring attitudes on a Likert scale (i.e. reasons in favour and barriers of pharmacist prescribing, preferred therapeutic areas of prescribing and prescribing models). A Chi square test was used to analyse categorical variables (i.e. demographics). Main outcome measure The opinion of hospital and community pharmacists regarding an expanded prescribing role. Results A response rate of 40.4 % was achieved (1,049/2,592). Where significant differences were located, community pharmacists were more supportive of all proffered potential reasons in favour of pharmacist prescribing (p < 0.05) whereas hospital pharmacists were more in agreement with all suggested barriers to such a role (p < 0.05). In a supplementary (collaborative) prescribing model, hospital pharmacists were more confident than community pharmacists in prescribing for heart failure (p < 0.001) and anticoagulant therapies (p = 0.004). In an independent prescribing model hospital pharmacists were more supportive of prescribing anticoagulant therapies (p = 0.002). Significant differences were found between the two groups in relation to their support for independent prescribing (p = 0.020) and extension of the emergency supply 3 days rule to 30 days (p = 0.011). Conclusion This study suggests that there are differences between hospital and community pharmacists in what they regard as potential reasons in favour of an expanded pharmacist prescribing role, perceived barriers to such a role and whether to prescribe independently of doctors. Hospital pharmacists’ attitudinal differences in terms of support for certain therapeutic areas of prescribing reflects probably their existing active role in clinical decision making processes in patients who are often seriously ill.

Keywords

Australia Community pharmacists Hospital pharmacists Independent prescribing Pharmacist prescribing Pharmacist role Supplementary prescribing 

Notes

Acknowledgments

The authors with to thank pharmacists who participated in this survey, Jenny Lalor for assistance with data entry and interpretation and Dr Richard Parsons for his assistance with statistical analysis.

Funding

None.

Conflicts of interest

Authors declare no conflict of interest.

References

  1. 1.
    Australian Bureau of Statistics (ABS). Census of population and housing. Canberra; http://www.censusdata.abs.gov.au/ (2006). Accessed 12 June 2012.
  2. 2.
    National Association of Pharmacy Regulatory Authorities. National Pharmacists/Pharmacies Statistics. Ottawa; http://napra.ca/pages/Practice_Resources/National_Statistics.aspx (2012). Accessed 20 June 2012.
  3. 3.
    Bureau of labor statistics, occupational outlook handbook, 2010–11 edition. Pharmacists. Washington DC. http://www.bls.gov/oco/ocos079.htm#emply (2012). Accessed 12 June 2012.
  4. 4.
    Council on credentialing in pharmacy. Scope of contemporary pharmacy practice: roles, responsibilities, and functions of pharmacists and pharmacy technicians. A Resource Paper of the Council on Credentialing in Pharmacy. Washington DC. http://www.pharmacycredentialing.org/ccp/Contemporary_Pharmacy_Practice.pdf (2009). Accessed 12 May 2012.
  5. 5.
    American College of Physicians–American Society of Internal Medicine. Pharmacist scope of practice-a position paper. Ann Intern Med. 2002;136:79–85.CrossRefGoogle Scholar
  6. 6.
    Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists—2003. Pharmacother. 2003;23:1210–25.CrossRefGoogle Scholar
  7. 7.
    Edmunds J, Calnan M. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med. 2001;53:943–55.PubMedCrossRefGoogle Scholar
  8. 8.
    Van Grootheest K, Olsson S, Couper M, De Jong-van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13:457–64.PubMedCrossRefGoogle Scholar
  9. 9.
    Galindo C, Olive M, Lacasa C, et al. Pharmaceutical care: pharmacy involvement in prescribing in an acute-care hospital. Pharm World Sci. 2003;25:56–64.PubMedCrossRefGoogle Scholar
  10. 10.
    Tonna AP, Stewart D, West D, McCaig D. Pharmacist prescribing in the UK; a literature review of current practice and research. J Clin Pharm Ther. 2007;32:545–56.PubMedCrossRefGoogle Scholar
  11. 11.
    Currie B. The future of Canadian pharmacy. Can Pharm J. 2009;72:126–7.CrossRefGoogle Scholar
  12. 12.
    Pharmaceutical Council of New Zealand. Pharmacist prescribers-one-step closer. Newsletter. June 2011. http://www.pharmacycouncil.org.nz/cms_show_download.php?id=218 (2011). Accessed 12 June 2012.
  13. 13.
    Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8:217–25.PubMedGoogle Scholar
  14. 14.
    Thomas J III, Bharmal M, Lin SW, Punekar Y. Survey of pharmacist collaborative drug therapy management in hospitals. Am J Health Syst Pharm. 2006;63:2489–99.PubMedCrossRefGoogle Scholar
  15. 15.
    Baird A. Independent and supplementary prescribing and PGDs. Nurs Stand. 2005;19:51–6.PubMedGoogle Scholar
  16. 16.
  17. 17.
    Mrtek RG, Catizone C. Pharmacy and the professions. In: Wetheimer AI, Smith MC, editors. Pharmacy practice social and behavioural aspects. 3rd edition ed. Baltimore: Williams and Wilkins; 1989. p. 23–41.Google Scholar
  18. 18.
    Cooper RJ, Anderson C, Avery T, et al. Nurse and pharmacist supplementary prescribing in the UK—a thematic review of the literature. Health Policy. 2008;85:277–92.PubMedCrossRefGoogle Scholar
  19. 19.
    Hoti K, Sunderland B, Hughes H, Parsons R. An evaluation of Australian pharmacist’s attitudes on expanding their prescribing role. Pharm World Sci. 2010;32:610–21.PubMedCrossRefGoogle Scholar
  20. 20.
    Humphrys P, O’Brien P. The relationship between skill utilization, professional orientation and job satisfaction for pharmacists. J Occup Psychol. 1986;59:315–26.CrossRefGoogle Scholar
  21. 21.
    Hoti K. Pharmacist prescribing in Australia. Thesis (dissertation). Curtin University of Technology; 2011.Google Scholar
  22. 22.
    The Australian Medical Association. Patient safety paramount in medication prescriptions, 2008 media releases. http://www.ama.com.au/node/3358 (2008). Accessed 21 June 2012.
  23. 23.
    Kondro W. Canada’s doctors assail pharmacist prescribing. CMAJ. 2007;177:558.Google Scholar
  24. 24.
    Anonymous. Prescribing readies community pharmacy (news). Pharm J. 2004;272:559.Google Scholar
  25. 25.
    Anonymous. Scottish supplementary prescribers get clinic funds (news). Pharm J. 2005;275:73.Google Scholar
  26. 26.
    Galt K. The key to pharmacist prescribing: collaboration. Am J Health Syst Pharm. 1995;52:1696–9.PubMedGoogle Scholar
  27. 27.
    Dooley MJ, Allen KM, Doecke CJ, et al. A prospective multicentre of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57:513–21.PubMedCrossRefGoogle Scholar
  28. 28.
    Mackenzie W, Peterson GM, Tenni PC, et al. Drug-related problems detected in Australian community pharmacies: the PROMISe trial. Ann Pharmacother. 2011;45:1067–76.CrossRefGoogle Scholar
  29. 29.

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Kreshnik Hoti
    • 1
    Email author
  • Jeffery Hughes
    • 1
  • Bruce Sunderland
    • 1
  1. 1.Curtin Health and Innovation Research Institute, School of PharmacyCurtin UniversityPerthAustralia

Personalised recommendations